| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-07 |
| mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-07 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
| mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-06 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |